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Abstract
Consumption of kombucha has been shown to promote human gut health and act as an
antibacterial agent against enteric pathogens. This thesis investigates if kombucha consumption changes
the composition of the human gut microbiota and aims to measure its inhibitory effects on the growth
of an enteric pathogen, Salmonella typhimurium. We predicted consumption of kombucha will alter the
composition of the gut microbiota and demonstrate antibacterial activity in the presence of S.
typhimurium. Research suggested that alterations in the gut microbiota is associated with multiple
chronic diseases. It is further noted that kombucha and other probiotics may be used to restore proper
gut health. Based on the literature, we suggest that kombucha has an effect on gut health. To test its
antibacterial activity, a Kirby-Bauer Disc Diffusion Assay was performed. Kombucha’s zone of inhibition
for S. typhimurium was compared to two antibiotics (ampicillin, ciprofloxacin) on TSA agar. Both
antibiotics displayed consistent inhibitory effects, however, kombucha did not inhibit S. typhimurium
growth. While kombucha and other probiotics affect the composition of the gut microbiota, kombucha
did not demonstrate antibacterial activity against S. typhimurium.
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Introduction
Fermentation:
Microbial fermentation is a metabolic process performed by microorganisms that convert sugars
into acids, alcohol, or gases (Lumen, 2020). This type of metabolic process occurs when microorganisms
lack sufficient amounts of inorganic final electron acceptors or do not have genes responsible for fueling
the Krebs cycle and electron transport chain (Lumen, 2020). Fermentation readily occurs when
microorganisms encounter susceptible substrates that can be used as a fuel source for various metabolic
systems (Hasan, Sultan, & Mar-E-Um, 2014). These metabolic interactions within the microorganism’s
environment include the decomposition of natural materials, which returns chemical elements back to
the source, and creates fermented food and beverage products (Hasan, Sultan, & Mar-E-Um, 2014).
Microbial fermentation has been extensively researched and utilized to produce vitamins,
alcohol, fermented foods, and fermented beverages (Bisen, 2014). Thus, microbial fermentation
provides various benefits to society. For example, fermented foods have demonstrated a multitude of
positive effects on the human body and are known to increase food nutritional quality through three
main mechanisms. First, fermented foods contain microorganisms that contain anabolic properties
allowing it to synthesize vitamins that unfermented food do not have. Secondly, fermentation breaks
down indigestible structures, in certain grains and seeds for example, which allows the release of
nutritional carbohydrates and proteins. The last mechanism that fermentation is known for is increasing
food's nutritional value. Microorganisms have the ability to split indigestible complex sugars into simple
sugar, which eases the digestion of foods in the human body (Hasan, Sultan, & Mar-E-Um, 2014). In
addition to fermented foods, microbial fermentation can also be applied to the field of medicine by
aiding in the creation of antibiotics, such as penicillin and tetracycline (Bisen, 2014).
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In terms of fermentation, there are two major types performed by microorganisms: lactic acid
fermentation and alcoholic fermentation (Lumen, 2020). Lactic acid fermentation is the chemical
conversion of pyruvate and NADH into lactic acid and NAD+. This type of fermentation can be used to
make fermented vegetables (sauerkraut), sourdough bread, fermented milks (yogurts and cheeses), as
well as protein-rich vegetable meat substitutes (National Academy Press, 1992). In comparison, alcoholic
fermentation converts sugars to ethanol, carbon dioxide, and other metabolic byproducts. This
biological conversion can produce a variety of consumable products such as wine, beer, spirits, vinegar,
and kombucha (ScienceDirect, 2017).

Probiotics:
Probiotics are living microbial organisms which when administered in adequate amounts can
provide health benefits for the host (Hegazy & Bedewy, 2010). Common foods that contain probiotics
are yogurt, fermented/unfermented milk, tempeh, juices, and other beverages like kombucha
(Kozyrovska et al., 2012). Bifidobacteria and Lactobacilli are two probiotics that are generally found in
consumable foods and beverages (Hegazy & Bedewy, 2010). Humans tend to consume probiotics
because of the extensive health outcomes they have on the internal environment such as aiding in
digestion, improving the immune system, and detoxifying the body (Kozyrovska et al., 2012). A
commercialized probiotic, Lactobacillus rhamnosus HN001, has proven to be beneficial in women's
medicine, specifically relating to vaginal and postpartum health (Cheng et al., 2019). Prior research
suggests that probiotics can be used to treat a variety of diseases, including liver disease, hypertension,
allergies, mental health impairments, and reduce sepsis mortality (Cheng et al., 2019). While there are
clear benefits to consuming probiotics in regard to combating certain diseases and promoting overall
health, the mechanisms by which probiotics carry out these activities are still of question (Hasan, Sultan,
& Mar-E-Um, 2014). Hasan, Sultan, & Mar-E-Um (2014) suggest that probiotics modify the pH of the gut,
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stimulate immunomodulatory cells, inhibit pathogens through antibacterial compounds, and
outcompete pathogens by binding to their receptor sites. In light of the recent findings, it is critical to
investigate the properties of probiotics and how certain probiotics, like kombucha, impacts human
health and overall the field of medicine.

Kombucha:
Kombucha is a probiotic beverage that originates from the fermentation of tea leaves leading to
the production of a symbiotic microbial community consisting of acetic bacteria and yeasts (Kozyrovska
et al., 2012; Kaewkod, Bovonsombut, & Tragoolpua, 2019). While bacteria and yeast live in community
in kombucha, it is important to note that they are each responsible for different metabolic pathways
that serve the beverage (Kaewkod, Bovonsombut, & Tragoolpua, 2019). Tea leaves undergo
fermentation in a sugar-rich environment and yeast cells break down sucrose to glucose (Kaewkod,
Bovonsombut, & Tragoolpua, 2019). Ethanol is produced from fermentation, which is a critical step
because acetic bacteria relies on ethanol to produce cellulose fiber and organic acids, and this
production of acids leads to a drop in the pH value of kombucha during fermentation (Kozyrovska et al.,
2012; Kaewkod, Bovonsombut, & Tragoolpua, 2019). These conversions form a cellulose mat, which is
formally known as the symbiotic culture of bacteria and yeast (SCOBY). Both ethanol and organic acid
products serve to protect the SCOBY by inhibiting other microbes from colonizing (Kozyrovska et al.,
2012). The bacteria typically found in probiotics are from the Lactobacillus and Bifidobacterium genus,
while Saccharomyces boulardii and S. cerevisiae are common yeasts that are stated to be probiotics
(Kozyrovska et al., 2012). Kombucha has gathered attention in the scientific community because of the
metabolites the SCOBY produces, and its suggested positive health effects (Kozyrovska et al., 2012). The
SCOBY’s metabolites have been known to promote gastrointestinal health, and more recently it has
been documented to demonstrate antimicrobial activity (Kozyrovska et al., 2012). Of interest in this
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thesis is how kombucha affects the composition of the human gut microbiota and further exploring its
antimicrobial properties against pathogens.

Kombucha and the human gut microbiota:
The term “microbiome” refers to the functional collection of microbes and their genetic material
in a particular environmental system, such as the human body (Lu & Liu, 2016). A “microbiota” describes
all the microbes in a microhabitat or a specific area of the microbiome. Each human harbors a
substantial number of microbial cells, inside and outside of the body. In total, the human microbiome
consists of 10 to 100 trillion symbiotic microorganisms (Ursell et al., 2012). When analyzing the human
microbiome, most microbial cells are found in the mouth and gut, and on the skin (Lloyd-Price, Abu-Ali,
& Huttenhower, 2016). The most sterile areas of the human microbiome are the blood and brain, due to
the blood brain barrier, and research notes the lungs may have sterility as well (Lloyd-Price, Abu-Ali, &
Huttenhower, 2016).
A specific area of the human microbiome, the gut microbiota, plays a critical role in the body's
overall health (Kozyrovka et al., 2012; Singh et. al, 2017). It is known that the human gut microbiota has
10!" residential microorganisms and 5,000 species of facultative and strict anaerobes that aid in
maintaining internal balance for the human host (Kozyrovka et al., 2012; Singh et. al, 2017). These
microorganisms include bacteria, viruses, fungi, and protozoa. In the intestinal microbiota,
Actinobacteria, Firmicutes, Bacteroidetes, Fusobacteria, and Proteobacteria, are the five types of
bacteria that are most often identified, with Firmicutes and Bacteroidetes being the most prevalent
(Kozyrovka et al., 2012; Singh et. al, 2017).
The microbial cells in the gut perform a variety of functions for humans. These include
synthesizing vitamins, generating metabolic byproducts for energy usage, and promoting immunity
(Singh et al., 2017). The gut microbiota also functions to gather energy from our diet, stimulate
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epithelial growth, regulate fat storage, and develop the immune system (Kozyrovska et al., 2012).
Therefore, it is important to consider the factors that alter the gut microbiota's bacterial makeup
because it can alter the overall health and disease state of an individual. A person’s diet, antibiotic
usage, age, genotype, and other factors (Fig. 1) play a large role in changing the composition of the gut
microbiota (Hasan & Yang, 2019; Kozyrovska et al., 2012). Due to the critical role the gut microbiota
plays in creating a healthy environment in the human body, it is of interest to study the mechanisms
that could potentially alter the gut microbiota. Microbial modifications in the gut have been shown to
have both negative and positive impacts, making it an area of research that is important to understand
(Singh et al., 2017).

A change in the gut microbiota has been associated with numerous chronic diseases, such as
obesity, type 1 diabetes, non-alcoholic fatty liver disease (NAFLD), hypertension, multiple sclerosis,
irritable bowel disorder, and gastrointestinal cancers (Jung et al., 2018; Kozyrovska et al., 2012).
Additionally, the overgrowth of Clostridium difficile, Proteus spp., and B. fragilis, which are intestinal
6

pathogens, can lead to severe functional disorders (Kozyrovska et al., 2012). Prior research
demonstrates that kombucha has healing-like properties on the composition of the gut microbiota in
mice with NAFLD. The study found that kombucha decreased the bacteria in the mice’s gut that
contributed to the progression of NAFLD (Jung et al., 2018). Could the consumption of kombucha reduce
the progression of other chronic diseases by beneficially altering the gut microbiota? Based on a primary
literature review, we hypothesized that kombucha will beneficially alter the composition of the human
gut microbiota, and kombucha consumption can be associated with various chronic disease states.

Kombucha’s antibacterial properties:
Bacterial infections among the human population is commonly treated with antibiotics, which
have the ability to kill (bactericidal) or inhibit (bacteriostatic) pathogen growth. However, many bacteria
have developed specific properties that resist the antibiotic’s mechanism of action. In the scientific and
medical communities, these strains of bacteria are considered antibiotic resistant (Mayo Clinic, 2020).
The Mayo Clinic (2020) explains that while many variables contribute to the emergence of antibiotic
resistance, high prescription dosages and wrongful prescription of antibiotics are major factors. Because
antibiotic resistance has become a prominent issue in medicine, researchers have placed an emphasis
on finding alternative antibacterials in hopes to decrease the use of antibiotics. Battacharya et al. (2016)
investigated the antibacterial potential of the traditional beverage, kombucha, to fight bacterial
infections, which raises the question: can alternative antibacterial products, like kombucha, be
consumed as a method to combat the evolving problem of antibiotic resistance?
Before answering this question, it is important to understand what properties of kombucha may
aid in its antibacterial activity. Previous research demonstrates that kombucha has antibacterial
properties against various enteric pathogens, such as E. coli, Shigella dysenteriae, S. typhimurium and
Vibrio cholera (Kaewkod, Bovonsombut, & Tragoolpua, 2019). This study concluded that the presence of
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organic acids in kombucha was positively correlated with antibacterial activity, and thus contributed to
its inhibitory effect on bacterial growth. However, Sreeramulu, Zhu, and Knol (2000) tested kombucha at
a neutral pH and found similar antibacterial activity against pathogenic microbes suggesting there are
other compounds that contribute to kombucha's inhibitory properties. Bhattacharya et al. (2016) points
to kombucha’s polyphenolic content as a main contributor to its bactericidal activity rather than organic
acids. Polyphenols are chemicals found in plant-based foods and are primarily known for their
antioxidant activity (Sign et al., 2017). This study identified catechin and isorhamnetin in its polyphenolic
fraction and concluded it has potent effects against enteric pathogens, suggesting polyphenols offer
other health benefits (Bhattacharya et al., 2016).
Fermentation time and the type of tea leaves also affect its antibacterial activity. Bhattarcharya
et al. (2016) fermented kombucha samples for 0, 7, 14 and 21 days before measuring its antibacterial
activity against various enteric pathogen strains such as, E. coli O157:H7, Vibrio cholerae N16961,
Shigella flexneri 2a 2457T, and S. typhimurium NCT 572. Their results state that without fermentation,
kombucha had weak inhibitory effects. Kombucha that was allowed to ferment for one week inhibited
the growth of all bacteria strains except S. Typhimurium (Bhattarcharya et al., 2016). However, the
samples that fermented for 14 and 21 days demonstrated equal bacteriostatic and bactericidal activity
against all strains of bacteria, except S. Typhimurium (Bhattacharya et al., 2016). Although S.
Typhimurium was more susceptible to 21-day fermented kombucha, resulting in a greater zone of
inhibition, Bhattarcharya et al. (2016) determined the 14-day kombucha had maximum inhibitory
activity. Furthermore, Battikh et al. (2012) found that kombucha fermented from green tea had a larger
zone of inhibition against S. Typhimuriuma than black tea. However, it is important to preface that a
similar study was conducted recently by Kaewkod, Bovonsombut, & Tragoolpua (2019), which concluded
that the type of tea leaf, whether it was green, black, or oolong, did not alter kombucha’s inhibition
against enteric pathogens.
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It is clear that further research should be conducted to better understand what properties of
kombucha create its antibiotic-like effects. While this question is important, the aim of the current study
is to investigate if kombucha can be used in substitute of an antibiotic to treat an enteric strain of S.
typhimurium. We hypothesized that kombucha would demonstrate antibacterial activity in the presence
of S. typhimurium, and thus potentially replacing the common treatment of antibiotics.

Methods
Bacteria isolation:
S. typhimurium (ATCC 13311) was used as the enteric pathogen in the current study. S.
typhimurium was inoculated from a frozen stock culture into sterile trypticase soy broth (TSB) and
grown overnight at 37°C. The overnight culture was used to streak for isolation to ensure that a pure
culture was being used to create the bacterial lawns of S. typhimurium.

Kombucha type and fermentation process:
One bottle of Deane’s Kombucha, Strawberry Lemon flavor, was used for the entirety of this
experiment. Deane’s kombucha undergoes a continuous brew in 30-gallon oak barrels. Once a mature
culture is formed, the SCOBY is added to the oak barrel and fermented for seven days. After seven days,
20 gallons is taken out of the original barrel to be infused with whole, organic fruit for three days. The
remaining ten gallons are used as the SCOBY for following brews. After the fruit has been infused,
fermentation continues in anaerobic conditions for four to seven more days. For purposes of this
experiment, total fermentation time was 14 days (Deane’s Kombucha, personal communication, Feb. 13,
2020).
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Kirby-Bauer disc diffusion assay:
Kirby-Bauer disc diffusion assay was used to test the inhibitory effects of kombucha (Deane’s
Kombucha: Strawberry Lemon flavor), two antibiotics [Ampicillin (AMP, 10 µg) and Ciprofloxacin (CIP, 5
µg)], and a control. This disc diffusion assay procedure has been previously described by Traub &
Leonhard (1994). AMP10 and CIP5 were placed in the center of the bacterial lawn. Whereas
experimental discs were soaked in kombucha for two minutes, control discs were soaked in water for
two minutes, and were then placed on the bacterial lawn. All plates were incubated at 37°C for 28 hours
and zones of inhibition were measured in millimeters (mm). A total of seven trials were used for the
experimental groups (kombucha, AMP10, CIP5), and three trials were used for the control.

Statistical analysis:
To determine if the inhibitory effects of kombucha, AMP10, and CIP5 were significant, GraphPad
Prism Scientific Software was used for statistical analysis (Motulsky et al., 2020). We computed p-values
to determine significance using the one-way ANOVA function in GraphPad. Two kinds of comparisons
were performed. First, to determine overall significance the mean of all inhibitory zones was analyzed.
Following this, we completed a Tukey multiple comparison between kombucha, AMP10, and CIP5 to
compare their antibacterial effects against S. typhimurium.
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Results
Kombucha’s effect on the composition of the gut microbiota:

In terms of relative bacterial abundance, MCD-fed (methionine-choline deficient) and MCD+KT
(MCD-fed and kombucha tea) experimental groups were associated with an alteration in the
composition of the gut microbiota compared to control groups. The Erysipelotrichi class (Firmicute
phylum) were not present in any of the control mice, however, were present in both of the experimental
groups. MCD-fed mice had a more significant increase in the relative abundance of the Erysipelotrichi
class when compared to MCD+KT mice. The Bacteroidia class (Bacteroidetes phylum) were most
abundant in the MCD+KT experimental groups. Furthermore, kombucha paired with the MCD diet led to
the highest amount of Bacteroidia. Relative abundance of Bacilli (Firmicute phylum) and
Betaproteobacteria (Proteobacteria phylum) were the highest in control mice, and least abundant in
MCD-fed mice (Jung et al., 2018).
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There was no significant difference between the dominant genera of the MCD or MCD+KT mice.
Allobaculum and Turicibacter play a role in the pathogenesis of NAFLD and were both significantly
decreased in the MCD-fed db/db mice after kombucha tea treatment. Also, the Clostridium genus was
not present in the control mice. Clostridium primarily existed in the MCD-fed mice, and the MCD+KT
mice were under-represented in the gut microbiota samples. Bacteria from the Lactobacillus genus were
more abundant in the MCD+KT mice compared to the MCD-fed mice, however, the control mice
represented the highest relative abundance of Lactobacillus. Additionally, Mucispirillum genus were only
found in the MCD+KT mice (Jung et al., 2018).
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Kombucha and its application to disease:

Based on histomorphology images of hepatocytes, the consumption of kombucha tea leads to
the reduction in fat accumulation surrounding the liver in mice with NAFLD. Image(s) of hepatocytes
represent that MCD-fed mice had excessive macrovesicular and microvesicular fat compared to the
normal-fed and kombucha-treated mice. Kombucha tea consumption for MCD-fed mice served to
display a lipoprotective effect on the liver (Jung et al., 2018).
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Kombucha tea and black tea consumption decreases the enzyme activity of α-amylase in the
plasma and pancreas and improves elevated blood glucose conditions of diabetic rats. The control group
rats endured significant increases of blood glucose concentrations, and α-amylase activities in the
plasma [(405 +/- 53%), (p<0.05)] and pancreas [(225 +/- 52%), (p<0.05)]. Consumption of kombucha tea
in diabetic rats has a greater inhibitory effect on α-amylase activities in the plasma and pancreas than
black tea. Furthermore, kombucha tea significantly suppresses hyperglycemic conditions more
effectively compared to black tea. More specifically, kombucha tea supplementation brought about a
significant decrease of 50 +/- 11% (p < 0.05) when referring to its effect on blood glucose concentration
(Aloulou et al., 2012).
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Kombucha’s antibacterial properties:

Zone of inhibition were measured for the antibiotic and kombucha soaked discs that were
placed on the bacterial lawns. The asterisks above the brackets represent the level of p-value
significance (*** p<0.001) (Fig. 5). Abundant S. typhimurium growth was present on all TSA agar plates
after 28 hours of incubation time. An ordinary one-way analysis of variance (ANOVA) results suggested
that there was overall statistical significance (p<0.001). Multiple comparisons were used to further
analyze the data by separating the antibiotics and kombucha. While both antibiotics, AMP10 and CIP5,
demonstrated inhibitory activity against the enteric pathogen, CIP5 had a larger mean zone of inhibition
(32.6 mm) which was significantly larger (p<0.001) than AMP10’s mean zone of inhibition (23.7 mm).
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The kombucha soaked discs did not suppress the growth of S. typhimurium, which is represented as a
mean zone of inhibition of zero, similar to the control. Both antibiotics had inhibitory zones that were
statistically larger than kombucha-treated samples.

Discussion
In the current study, we conducted a literature review on how kombucha affects the gut
microbiota and completed an experiment to determine if kombucha’s antibacterial properties would
demonstrate successful inhibition against S. typhimurium. In regard to the gut microbiota, our prediction
that kombucha would alter the gut was supported and kombucha consumption can help manage certain
chronic diseases. In regard to the laboratory experiment which analyzed kombucha’s antibacterial
capacity, we originally predicted that kombucha would inhibit the growth of S. typhimurium due to its
said antibacterial properties. However, this prediction was not supported by the data collected from the
Kirby-Bauer disc diffusion assay.

Kombucha’s effect on the composition of the gut microbiota and its application to
disease:
It is widely known in scientific research that imbalances in the gut microbiota contribute to
disease (Hasan & Yang, 2019). Because of this knowledge, many have researched what causes
disturbances in the gut in hopes to prevent these agents from generating human disease. Scientific
literature has expressed that our diet may be a contributing factor to alterations in gut health (Hasan &
Yang, 2019; Singh et al., 2017). Furthermore, Kozyrovska et al. (2012) and Singh et al. (2017) state that
probiotic microorganisms help balance the intestinal microbiota. With that being considered, it seems to
be known that understanding how diet affects gut health is important because of its association to
disease. With that being considered, based on the literature review, it is evident that kombucha affects
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the composition of the gut microbiota, and can improve various chronic disease states, such as NAFLD
and diabetes (Aloulou et al., 2012; Jung et al., 2018; Kozyrovska et al., 2012).
The study conducted by Jung et al. (2018) demonstrates the beneficial applications that
kombucha has against NAFLD. Twelve eight-week old mice were split into three different dietary groups.
Four mice received a normal diet and water (control), while the other eight mice consumed a
methionine/choline-deficient (MCD) diet. While all eight of the MCD-fed mice drank water, half of the
mice were administered 2g/kg of kombucha powder which was dissolved in their water. It is important
to mention that MCD diets result in liver injury and are commonly used in research to induce nonalcoholic steatohepatitis (NASH), which is a more progressive form of NAFLD (Machado et al., 2015).
As depicted in Fig. 4, the consumption of kombucha tea led to the reduction in fat accumulation
surrounding the liver and serves to produce a lipoprotective effect on the liver (Hyun et al., 2016). The
MCD-fed mice without the administration of kombucha had more severe steatosis with increased fat
droplets when compared to MCD+KT mice (Jung et al., 2018). Additionally, in relation to the
composition of the gut microbiota, Jung et al. (2018) noted that both the control and MCD-fed mice
demonstrated a 1:1 ratio of Firmicutes to Bacteroidetes. However, it is important to mention that
patients with NASH have a lower level of Bacteroidetes, meanwhile it was found that in MCD+KT mice,
Bacteroidetes in the intestinal microbiota increased (Fig. 2; Jung et al., 2018). This signifies that
kombucha was able to alter the composition of the gut microbiota by increasing the relative abundance
of Bacteroidetes. This compositional change decreases the 1:1 ratio of Firmicutes to Bacteroidetes, and
thus serves as a protective mechanism against NAFLD. While this is an interesting finding, causal claims
cannot be made, and this ratio alteration may only be a correlational finding.
Furthermore, Allobaculum and Turicibacter, which are dominant bacteria that contribute to the
progression of NAFLD, were decreased in the MCD+KT mice (Jung et al., 2018). Kombucha alters the gut
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microbiota by lowering the amounts of Allobaculum and Turicibacter in the gut, as seen in the MCD+KT
mice. While this provides additional evidence that kombucha slows the advancement of NAFLD, the
mechanism is not understood clearly. It is predicted that the microbial structural or chemical
components of kombucha tea might contribute to the decreased progression of NAFLD (Jung et al.,
2018).
It is also emphasized that MCD+KT mice had more Lactobacillus present in their gut than MCDfed mice. This is of particular significance because this genus of bacteria has several protective effects
that work against the pathogenesis of NAFLD (Jung et al., 2018). Another alteration that occurred in the
intestinal microbiota of the MCD+KT mice was a presence of Mucispirillum genus (Fig. 3; Jung et al.,
2018). Previous studies explain that there is a positive correlation between Mucispirillum and the
hormone, leptin (Ravussin et al., 2012). This is advantageous because leptin acts on the brain to
suppress hunger which will decrease food intake and body fat while increasing metabolic activity
(Brennan & Mantzoros, 2006). Although this correlation isn’t directly related to NAFLD, the increase in
Mucispirillum (due to kombucha consumption) may lead to an improved overall health-status and a
decrease in body fat.
The consumption of kombucha can also improve hyperglycemia in diabetic subjects. In
comparison to black tea, kombucha produces a higher inhibitory effect of α-amylase in the plasma and
pancreas of alloxan diabetic rats. Alloxan is a toxin which creates excess reactive oxygen species that
damages pancreatic beta cells and inhibits insulin production in response to glucose in the blood
(Aloulou et al., 2012). The key digestive enzyme, α-amylase, hydrolyses alpha bonds of starches, which
yields maltose and glucose molecules (Aloulou et al., 2012). As the activity of α-amylase increases, blood
glucose levels will also increase, and this can lead to hyperglycemic conditions. However, kombucha
consumption significantly inhibits the activity of α-amylase, decreasing its ability to break down and
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absorb glucose, which prevents the rat from entering hyperglycemic conditions (Fig. 5; Aloulou et al.,
2012). While kombucha has a multitude of metabolites that enhance its health benefits, the beverages
polyphenolic composition contributes most to its antidiabetic properties of reducing α-amylase activity
in the intestines of rats (Aloulou et al., 2012).
Before patients start an antidiabetic drug, life-style interventions are initially suggested in
efforts to control blood glucose without the need of any medication (Chaudhury et al., 2017). Since the
consumption of kombucha significantly inhibits the activity of α-amylase in alloxan diabetic rats, this
type of fermented beverage could be incorporated into a patient’s initial life-style intervention plan. The
integration of this natural-probiotic beverage early on in one’s diabetic diagnosis, may prevent the
individual from relying on pharmaceuticals to control their blood glucose levels. This premature action
could also avoid the side effects that many diabetic medications have on the individual. Metformin, the
best first-line drug therapy for type 2 diabetes, has side effects such as dizziness, muscle pain, difficulty
breathing, irregular heartbeat, and others (Nasri & Rafieian-Kopaei, 2014).

Analysis of kombucha’s antibacterial properties against S. typhimurium:
In the current study, kombucha did not inhibit the growth of S. typhimurium which was
demonstrated by a zone of inhibition of zero (Fig. 6). However, both CIP5 and AMP10 inhibited the
growth of S. typhimurium signifying that this strain, derived from S. typhimurium (ATCC 13311), was
susceptible to these antibiotics. While both antibiotics successfully inhibited growth, CIP5 had a
significantly larger mean zone of inhibition (32.6 mm) than AMP10 (23.7 mm), which represents S.
typhimurium was more sensitive to CIP5 (Fig. 6). This is of interest because S. typhimurium has
demonstrated antibiotic resistance patterns which has raised concerns and limited treatment options to
fight this enteric infection (Wang et al., 2019). Prior evaluations of antibiotic resistance in 11,447 strains
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of S. typhimurium suggests that S. typhimurium is most susceptible to fluoroquinolones, meanwhile, S.
typhimurium displayed high resistance against ampicillin (Wang et al., 2019). The fluoroquinolone
compound, ciprofloxacin, is recommended to treat Salmonella infections due to its broad-spectrum
properties (Fàbrega & Vila, 2013). These results coincide with our findings as the plated CIP5 antibiotic
disc inhibited S. typhimurium growth to a greater degree than AMP5 (Fig. 6). However, AMP5 still
prevented the growth of S. typhimurium suggesting that although its inhibitory effect was not as
effective as CIP5, it is not necessarily resistant to S. typhimurium (ATCC 13311) in the current study.
Understanding which antibiotics have stronger inhibitory mechanisms against S. typhimurium is
beneficial knowledge for healthcare providers who are looking to treat patients with this enteric
infection. If it is understood that ciprofloxacin is a better treatment option than ampicillin for S.
typhimurium infections, the patient will decrease their exposure to multiple antibiotics, helping to
reduce the occurrence of antibiotic-resistance.
It was found that kombucha did not inhibit the growth of S. typhimurium, however, this is not
supported by previous literature. S. typhimurium was found to be sensitive to kombucha at a natural pH
(without any pH adjustments), neutral pH of 7, and when kombucha was exposed to heat (Sreeramulu,
Zhu, & Knol, 2000). Additionally, it is highlighted that antimicrobial activity increased with the length of
fermentation, thus kombucha fermented for a period of 10-14 days, demonstrated maximum zones of
inhibition (30-35 mm) against S. typhimurium (ATCC 13311) (Sreeramulu, Zhu, & Knol, 2000). Differences
in our results may be due to the strain of bacteria used in the present study. The strain used was derived
from S. typhimurium (ATCC 13311) that Saint John’s University has had for many years, so there are
likely lab adaptations (mutations). The S. typhimurium strain may have mutated and acquired resistant
mechanisms that are effective against weaker antibacterial products (kombucha beverage used), which
limits our ability to draw conclusions from these results. Furthermore, it is important to recall that
Deane’s Kombucha carried out its fermentation process in oak barrels, whereas typical kombucha
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fermentation is performed in glass brewing vessels (Sreeramulu, Zhu, and Knol, 2000). Future research
should explore how the type of fermentation vessel affects kombucha’s antibacterial properties. If
research finds that one type of fermentative vessel produces greater antibacterial properties, then
suggestions could be made in efforts to have consumers receive the highest health-related benefits, and
thus be implemented as a useful antibacterial agent. With that being considered, this natural beverage
may be used as an alternative to antibiotics, helping to decrease resistance around the globe.
When compared to an antibiotic control, kanamycin, kombucha demonstrated a smaller zone of
inhibition than the antibiotic (Bhattacharya et al., 2016). However, it was concluded that kombucha
could be used as an antibacterial agent against enteric pathogens due to its polyphenolic content that
gives rise to its bactericidal properties (Bhattacharya et al., 2016). While our study does not further
support this notion, kombucha’s antibacterial properties are still considered cost-effective, accessible,
and potentially a safer alternative when compared to the prescription of broad-spectrum antibiotics
(Bhattacharya et al., 2016).

Conclusion
Kombucha enhances the composition of the gut microbiota and is applicable to reducing the
progression of chronic diseases, more specifically, NAFLD and diabetes mellitus. However, the current
study does not demonstrate kombucha’s antibacterial properties. Moving forward, kombucha should
still be considered as an antibacterial agent against enteric pathogens, such as S. typhimurium (ATCC
13311). Based on the literature review and current study, we would recommend individuals to
incorporate kombucha into their diet because of its beneficial effects on the gut microbiota and may be
helpful to fight enteric infections. Future research should focus on whether or not kombucha has
antibiotic-like effects in humans with enteric diseases. If this is established, then kombucha could
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potentially be used as a substitute for antibiotics. Furthermore, we would suggest healthcare providers
turn to fermented foods and beverages, like kombucha, which contain antibacterial properties as a first
line in fighting infections. This would reduce the medical communities’ reliance on antibiotics, overall
helping to control the spread of antibiotic-resistance.
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